TAKEDA PHARMACEUTIC-SP ADR

TAK · NYSE

Updated at 2026-10-14 08:03:32

$18.52-0.85%
Today's High
$18.82
Today’s Low
$18.52
TAKEDA PHARMACEUTIC-SP ADR (TAK) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$18.79
Previous Close
$18.68
Volume
1.9M
Market Cap
$9.32T
P/E Ratio
--
EPS
$-103.49

Previous Day Range

$18.65$18.79

52-Week Range

$4,102.00$6,033.00

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Headquarters
1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO, JAPAN, 103-8668
Country
JP
Listing Date
1949-05-16
Fiscal Year End
March
Shares Outstanding
1.6B
CIK
0001395064

Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.

Financial Metrics

Revenue

2026-06-30

$1.21T

2026-03-31

$1.11T

2025-12-31

$1.21T

2025-09-30

$1.11T

Operating Expenses

2026-06-30

$611.8B

2026-03-31

$496.26B

2025-12-31

$466.28B

2025-09-30

$663.74B

Net Income

2026-06-30

$113.19B

2026-03-31

-$24.76B

2025-12-31

$105.51B

2025-09-30

-$11.8B

Net Profit Margin

2026-06-30

9.27%

2026-03-31

-2.22%

2025-12-31

8.69%

2025-09-30

-1.06%

Earnings Per Share

2026-06-30

$0.48

2026-03-31

$-0.74

2025-12-31

$0.20

2025-09-30

$-0.02

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

$389.2B

2026-03-31

$154.87B

2025-12-31

$452.77B

2025-09-30

$296.29B

Effective Tax Rate

2026-06-30

30.39%

2026-03-31

53.77%

2025-12-31

22.5%

2025-09-30

141.63%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.